OliX Pipeline
  • OLX401A
    Neuropathic Pain
  • OLX701A
    Liver Fibrosis
  • OLX801A
    Cancer immunotherapy

OliX’s asymmetric siRNA(asiRNA) technology not only shows comparable gene silencing compared with a conventional siRNA, but also significantly reduces siRNA-mediated side effects, such as off-target gene silencing and immune stimulation. cp-asiRNA is a proprietary RNAi triggering structure developed by OliX, which can efficiently internalize and knock-down target gene silencing without any transfection reagents or delivery vehicles.